Spravato is now the first stand-alone therapy for treatment-resistant depression, for patients who haven’t responded to oral ...

The announcement was welcome news for those with major depressive disorder, which affects an estimated 8.3% of the adult ...

Analysts discuss Johnson & Johnson's outlook, highlighting MedTech challenges, litigation risks, pipeline opportunities, and mixed performance across segments.

Vaccines, antibiotics, antiviral medications and anti-inflammatory drugs are all associated with a reduced risk of dementia, researchers reported in a study published Tuesday in the journal ...

Overall, women with MS have a 26% increased risk of mental illness during pregnancy and a 33% increased risk after giving birth, compared to women without the degenerative nerve disease.

A nasal spray therapy for treatment-resistant major depressive disorder (MDD) has now been approved by the Food and Drug Administration (FDA) for use on its own, making it the first-ever approved ...

Gov. Phil Scott (R-Berlin) flagged the public safety crisis and the rise in repeat offenders as one of his main priorities to ...

Sean “Diddy” Combs filed a defamation lawsuit for $50 million against an accuser who claimed to have incriminating sex tapes, as well as their attorney and the parent company of NewsNation.

Netflix documentary Fights, Camera, Action spotlights the show's former producers and their desperate attempts to raise the ...

In a three-hour committee meeting on Wednesday, senators on the Health and Provider Services Committee revived some ...

From humble beginnings to becoming the Vice President of the United States, Speaker Mike Johnson captured the special moment ...

Analyst Tim Anderson of Bank of America Securities reiterated a Hold rating on Johnson & Johnson (JNJ – Research Report), reducing the ...